17β-Estradiol Inhibits Lysophosphatidylcholine-Induced Apoptosis in Cultured Vascular Smooth Muscle Cells
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Coronary heart disease (CHD) risk increases in women after menopause, but menopausal hormone therapy (MHT) helps prevent CHD if started early after menopause. To explore the mechanism underlying the direct vascular actions of estrogen, the effects of 17β-estradiol (E2) on apoptosis of vascular smooth muscle cells (VSMCs) induced with lysophosphatidylcholine (lysoPC), an active component of oxidized low-density lipoprotein, were investigated in the present study. Methods: VSMCs were isolated from rat aortas. Apoptosis and protein expression of caspases were assessed using propidium iodide staining and Western blot analysis, respectively. Intracellular formation of reactive oxygen species (ROS) was examined using dichlorofluorescein diacetate, a cell-permeable oxidation-sensitive probe, and quantitated with flow cytometry. Nuclear factor-κB (NF-κB) activation was determined after transfection with a reporter plasmid containing the luciferase reporter gene. Results: After pre-treatment for 24 hours, 17β-E2 suppressed lysoPC-induced (15 mM) apoptotic cell death in a dose-dependent manner with statistical significance at near physiological concentration. 17β-E2 (10−6 M) also increased protein levels of caspase-9 and -8 precursors and decreased the active form of caspase-3. Western blot analysis using subcellular fractions showed that 17β-E2 decreased mitochondrial Bax levels and concomitantly increased cytosolic Bax expression. Furthermore, intracellular production of ROS and NF- κB-mediated transcriptional activity were reduced with 17β-E2. In addition, estrogen effects on apoptosis were partially blocked by ICI 182,780, a specific estrogen receptor antagonist. Conclusions: In cultured VSMCs treated with lysoPC, 17β-E2 reduced apoptotic cell death by down-regulating both extrinsic and intrinsic apoptosis pathways, contributing to the preventive action of MHT against CHD.
Abstract
Objectives: Coronary heart disease (CHD) risk increases in women after menopause, but menopausal hormone therapy (MHT) helps prevent CHD if started early after menopause. To explore the mechanism underlying the direct vascular actions of estrogen, the effects of 17β-estradiol (E2) on apoptosis of vascular smooth muscle cells (VSMCs) induced with lysophosphatidylcholine (lysoPC), an active component of oxidized low-density lipoprotein, were investigated in the present study. Methods: VSMCs were isolated from rat aortas. Apoptosis and protein expression of caspases were assessed using propidium iodide staining and Western blot analysis, respectively. Intracellular formation of reactive oxygen species (ROS) was examined using dichlorofluorescein diacetate, a cell-permeable oxidation-sensitive probe, and quantitated with flow cytometry. Nuclear factor-κB (NF-κB) activation was determined after transfection with a reporter plasmid containing the luciferase reporter gene. Results: After pre-treatment for 24 hours, 17β-E2 suppressed lysoPC-induced (15 mM) apoptotic cell death in a dose-dependent manner with statistical significance at near physiological concentration. 17β-E2 (10−6 M) also increased protein levels of caspase-9 and -8 precursors and decreased the active form of caspase-3. Western blot analysis using subcellular fractions showed that 17β-E2 decreased mitochondrial Bax levels and concomitantly increased cytosolic Bax expression. Furthermore, intracellular production of ROS and NF- κB-mediated transcriptional activity were reduced with 17β-E2. In addition, estrogen effects on apoptosis were partially blocked by ICI 182,780, a specific estrogen receptor antagonist. Conclusions: In cultured VSMCs treated with lysoPC, 17β-E2 reduced apoptotic cell death by down-regulating both extrinsic and intrinsic apoptosis pathways, contributing to the preventive action of MHT against CHD.
참고문헌 (25)
- Bennett MR, "Vascular smooth muscle cells in atherosclerosis", Circ Res, 118, pp.692~702 (2016)
- Kattoor AJ, "Oxidative stress in atherosclerosis", Curr Atheroscler Rep, 19, pp.42~ (2017)
- Pant S, "Inflammation and atherosclerosis--revisited", J Cardiovasc Pharmacol Ther, 19, pp.170~178 (2014)
- Elmore S, "Apoptosis : a review of programmed cell death", Toxicol Pathol, 35, pp.495~516 (2007)
- McCarthy NJ, "The regulation of vascular smooth muscle cell apoptosis", Cardiovasc Res, 45, pp.747~755 (2000)
- Silvestre-Roig C, "Atherosclerotic plaque destabilization : mechanisms, models, and therapeutic strategies", Circ Res, 114, pp.214~226 (2014)
- Sawabe M, "Vascular aging : from molecular mechanism to clinical significance", Geriatr Gerontol Int, 10(Suppl 1), pp.S213~S220 (2010)
- 이승준, "Arterial Ageing", Korean Circulation Journal, 43(2), pp.73~79 (2013), 대한심장학회
- Kita T, "Role of oxidized LDL in atherosclerosis", Ann N Y Acad Sci, 947, pp.199~205 (2001)
- 이동윤, "Lysophosphatidylcholine의 혈관평활근세포에 대한 세포 독성", 대한폐경학회지, 18(3), pp.139~146 (2012), 대한폐경학회
- Muka T, "Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality : a systematic review and meta-analysis", JAMA Cardiol, 1, pp.767~776 (2016)
- Manson JE, "Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials", JAMA, 310, pp.1353~1368 (2013)
- Mendelsohn ME, "Molecular and cellular basis of cardiovascular gender differences", Science, 308, pp.1583~1587 (2005)
- Owens GK, "Expression of smooth muscle-specific alpha-isoactin in cultured vascular smooth muscle cells : relationship between growth and cytodifferentiation", J Cell Biol, 102, pp.343~352 (1986)
- 윤병구, "Impact of Lysophosphatidylcholine on the Plasminogen Activator System in Cultured Vascular Smooth Muscle Cells", Journal of Korean Medical Science, 27(7), pp.803~810 (2012), 대한의학회[DOI]
- Yoon BK, "17Betaestradiol inhibits proliferation of cultured vascular smooth muscle cells induced by lysophosphatidylcholine via a nongenomic antioxidant mechanism", Menopause, 8, pp.58~64 (2001)
- Grootaert MOJ, "Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis", Cardiovasc Res, 114, pp.622~634 (2018)
- Kabe Y, "Redox regulation of NF-kappaB activation : distinct redox regulation between the cytoplasm and the nucleus", Antioxid Redox Signal, 7, pp.395~403 (2005)
- Clarke MC, "Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration", Circ Res, 102, pp.1529~1538 (2008)
- Clarke MC, "Vascular smooth muscle cell apoptosis induces interleukin-1-directed inflammation : effects of hyperlipidemia-mediated inhibition of phagocytosis", Circ Res, 106, pp.363~372 (2010)
- 김남호, "Apoptosis in Cardiovascular Diseases:Mechanism and Clinical Implications", Korean Circulation Journal, 40(7), pp.299~305 (2010), 대한심장학회
- Sudoh N, "Estrogen prevents oxidative stress-induced endothelial cell apoptosis in rats", Circulation, 103, pp.724~729 (2001)
- Hsieh DJ, "17β-estradiol and", or estrogen receptor β attenuate the autophagic and apoptotic effects induced by prolonged hypoxia through HIF-1α-mediated BNIP3 and IGFBP-3 signaling blockage, 2015, pp.36, 274~284
- Canugovi C, "Increased mitochondrial NADPH oxidase 4(NOX4)expression in aging is a causative factor in aortic stiffening", Redox Biol, 26, pp.101288~ (2019)
- da Costa LS, "Effects of hormone replacement therapy or raloxifene on ambulatory blood pressure and arterial stiffness in treated hypertensive postmenopausal women", Am J Cardiol, 94, pp.1453~1456 (2004)